Conclusiones. Muchos países carecen de estudios epidemiológicos sobre la miastenia
grave, y en otros, los datos comunicados se centran en un hospital de referencia, lo que hace …

Objective To study baseline serum neurofilament light chain (sNfL) levels as a prognostic
biomarker in Guillain-Barré syndrome (GBS). Methods We measured NfL in serum (98 samples…

Background and Objectives To study the clinical and laboratory features of antineurofascin-155
(NF155)–positive autoimmune nodopathy (AN). Methods Patients with anti-NF155 …

Background Guillain–Barré syndrome (GBS) is an acute inflammatory neuropathy with a
heterogeneous presentation. Although some evidences support the role of autoantibodies in its …

… 1 , Agustín Gómez De la Cámara, María Victoria Ribera Canudas, Jordi Montero Homs,
Emilio Blanco Tarrío, Antonio Collado Cruz, Avelino Ferrero Méndez, Joan Molet Teixidó …

Myasthenia gravis is an autoimmune disease caused by the presence of specific antibodies
targeting different postsynaptic components of the neuromuscular junction, and is clinically …

Purpose of Review To improve our clinical understanding of facial onset sensory and motor
neuronopathy (FOSMN). Recent Findings We identified 29 new cases and 71 literature cases…

Myasthenia gravis is an autoimmune disease caused by the presence of specific antibodies
targeting different postsynaptic components of the neuromuscular junction, and is clinically …

Background Most amyotrophic lateral sclerosis (ALS) patients lack a monogenic mutation.
This study evaluates ALS cumulative genetic risk in an independent Michigan and Spanish …

O proceso asistencial integrado da esclerose lateral amiotrófica, elaborouse co obxectivo
de crear un proceso de traballo común en todas as áreas para facilitar a asistencia sanitaria …